Editas Medicine, Inc.
CRISPR-related methods and compositions with governing gRNAS

Abstract:

Disclosed herein are methods and compositions useful in targeting a payload to, or editing a target nucleic acid, where a governing gRNA molecule is used to target, optionally inactivate, a Cas9 molecule or a Cas9 molecule/gRNA complex.